ATX
Click for more information
4.92% 6.4¢ amplia therapeutics limited

News: ATX Amplia Therapeutics Says Approval From Korean Regulator, page-8

  1. Dimitrios63
    57 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    07/12/23
    17:30
    Post #: 71332661
    I have found with bio techs at this point of the trial time that the market is usually very cautious to the extreme that they will actually price in failure.

    So that IF and when they do announce a positive endpoint that's when you get the ''binerary effect'' in the share price regardless of what situation the general market is in.

    Just my opinion here and DYOR.
    Last edited by Dimitrios63: 07/12/23
    ATX Price at posting: 7.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
HAR Haranga resource upgrade builds confidence in Saraya uranium project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.4¢ 		Change
0.003(4.92%) 		Mkt cap ! $17.38M
Open High Low Value Volume
6.1¢ 6.6¢ 6.1¢ $28.65K 462.7K

Buyers (Bids)

No. Vol. Price($)
2 50642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 131151 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.